The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

May 31, 2011

Conditions
Hypertension
Interventions
DRUG

Fimasartan 60mg

Fimasartan 60mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.

DRUG

Fimasartan 120mg

Fimasartan 120mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.

DRUG

Candesartan cilexetil

Candesartan 8mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.

Trial Locations (1)

110-750

KyungPook National University Hospital, Daegu

Sponsors
All Listed Sponsors
collaborator

Kyungpook National University Hospital

OTHER

collaborator

Gyeongsang National University Hospital

OTHER

collaborator

Keimyung University

OTHER

collaborator

Kosin University Gospel Hospital

OTHER

collaborator

Daegu Catholic University Medical Center

OTHER

collaborator

Dong-A medical center

UNKNOWN

collaborator

Pusan National University Yangsan Hospital

OTHER

collaborator

Yeungnam University Hospital

OTHER

collaborator

Ulsan University Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Pusan National University Hospital

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY